XTNT

Xtant Medical Holdings Inc. Common Stock (XTNT)

Stock · AMEX · Health Care

$0.2843as of 10/16/2026

Price chart

Open in TradingView

Active signals

BOLL Breakdown92.9%Support Reject7.0%200 SMA Touch0.0%
Resistance level
$0.316937
Industry
Medical/Dental Instruments

XTNT Signal Track Record

How signals performed across all stocks →

What XTNT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike52-1.5%48%
Bollinger Band Breakout23-10.2%35%
Bollinger Band BreakdownActive now20+9.3%70%
200-Day Moving Average TouchActive now14+6.6%71%
Any 20-session window (baseline)-1.7%44%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About XTNT

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal steril…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
151

Fundamentals

1-day range
$0.28$0.3068
Market cap
$62.09M
P/E (trailing)
23.84
P/E (forward)
-9.56
EPS (trailing)
$-0.08
Dividend yield
—
Beta
-0.31
Avg. volume
1.69M
Dividend pay date
February 14, 2018
52-week range
$0.2702$0.95
Next earnings: November 10, 2026 · EPS estimate $-0.02confirmed

How Xtant Medical Holdings Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$133.93MNet Income$4.97M (4%)SG&A$74.89M (56%)Cost of Revenue$49.65M (37%)R&D$2.10M (2%)Tax$2.03M (2%)XTNT

Source: 10-K filed Mar 31, 2026 · via SEC EDGAR / Finnhub

Gross Profit$84.27M(63%)
Operating Income$7.28M(5%)

Forecasts

3 analyst ratings

Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$1.5
+427.6%
Median
$1
+251.7%
Low
$0.6
+111.0%

Xtant Medical Holdings Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • XTNT
    Xtant Medical Holdings Inc. Common Stock
    $0.29
    ▼ 3.33%
    Market cap $62.09MP/E 23.84
    $0.2702$0.95
  • DXR
    Daxor Corporation Common Stock
    $10.05
    ▼ 1.47%
    Market cap $61.18MP/E 10.12
    $8.56$14.76
  • QTEX
    QTREX Quantum Ltd. Ordinary Shares
    $1.5
    ▼ 5.06%
    Market cap $59.05MP/E —
    $0.283$3.85
  • NYXH
    Nyxoah SA Ordinary Shares
    $1.11
    ▼ 6.72%
    Market cap $57.20MP/E —
    $1.11$5.3
  • DRIO
    DarioHealth Corp. Common Stock
    $4.82
    ▼ 6.04%
    Market cap $56.88MP/E —
    $5.03$16.5
  • LNSR
    LENSAR Inc. Common Stock
    $5.8
    ▼ 3.81%
    Market cap $70.43MP/E 2.15
    $4.95$12.94
  • MDAI
    Spectral AI Inc. Class A Common Stock
    $1.51
    ▼ 1.95%
    Market cap $52.83MP/E —
    $1.18$2.97

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
2.59M
Disposed
45.8K

Institutional Ownership

March 31, 2026

Total shares held
80.48M
Total value held
$44.81M
Institutional holders
33
Top holders this quarter
  • Unknown68.39M
  • Unknown5.98M
  • Unknown2.01M
  • Unknown987.4K
  • Unknown529.2K
  • Unknown412.0K
  • Unknown362.2K
  • Unknown350.0K
  • Unknown180.3K
  • Unknown164.1K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.